Beranda › Limfoma Hodgkin › New Jersey
Uji klinis Limfoma Hodgkin di New Jersey
5 studi untuk Limfoma Hodgkin mencari peserta di lokasi di New Jersey.
Kota di New Jersey
Teks studi resmi (Bahasa Inggris)
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03618550A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Hackensack University Medical Center, Hackensack
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Hackensack University Medical Center, Hackensack
Menerima pesertaStudi observasional
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06098430A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06377566Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 4 Mar 2026 · NCT01788839Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.